Alexandre Jagerschmidt

838 total citations
20 papers, 350 citations indexed

About

Alexandre Jagerschmidt is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Alexandre Jagerschmidt has authored 20 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Physiology and 6 papers in Immunology. Recurrent topics in Alexandre Jagerschmidt's work include Neuropeptides and Animal Physiology (5 papers), Asthma and respiratory diseases (5 papers) and Systemic Sclerosis and Related Diseases (4 papers). Alexandre Jagerschmidt is often cited by papers focused on Neuropeptides and Animal Physiology (5 papers), Asthma and respiratory diseases (5 papers) and Systemic Sclerosis and Related Diseases (4 papers). Alexandre Jagerschmidt collaborates with scholars based in France, United States and Germany. Alexandre Jagerschmidt's co-authors include Oliver Distler, Stéphane Illiano, Yannick Allanore, Dinesh Khanna, Eric Boitier, Christopher P. Denton, Inoncent Agueusop, Nathalie Goudreau, B.P. Roques and Bernard Maigret and has published in prestigious journals such as Biochemical Journal, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Alexandre Jagerschmidt

20 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandre Jagerschmidt France 10 166 105 91 72 56 20 350
Chiyuki Furukawa Japan 5 269 1.6× 97 0.9× 34 0.4× 17 0.2× 42 0.8× 6 434
Alison Kraus Germany 11 284 1.7× 78 0.7× 18 0.2× 31 0.4× 93 1.7× 18 473
TaeJeong Oh South Korea 10 210 1.3× 64 0.6× 14 0.2× 75 1.0× 18 0.3× 14 385
Vincenzo Ciocca United States 8 156 0.9× 242 2.3× 41 0.5× 26 0.4× 97 1.7× 12 508
Fiamma Berner Switzerland 7 90 0.5× 71 0.7× 47 0.5× 31 0.4× 120 2.1× 11 459
Mitchell I. Parker United States 10 145 0.9× 35 0.3× 14 0.2× 21 0.3× 18 0.3× 15 294
Yasuhito Tonomoto Japan 10 182 1.1× 207 2.0× 37 0.4× 17 0.2× 50 0.9× 12 477
Kayo Ijichi Japan 12 171 1.0× 234 2.2× 31 0.3× 17 0.2× 20 0.4× 29 496
Sandra Gallagher United States 9 72 0.4× 32 0.3× 21 0.2× 67 0.9× 107 1.9× 11 312
Takanobu Ubai Japan 11 206 1.2× 82 0.8× 48 0.5× 26 0.4× 38 0.7× 23 433

Countries citing papers authored by Alexandre Jagerschmidt

Since Specialization
Citations

This map shows the geographic impact of Alexandre Jagerschmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Jagerschmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Jagerschmidt more than expected).

Fields of papers citing papers by Alexandre Jagerschmidt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Jagerschmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Jagerschmidt. The network helps show where Alexandre Jagerschmidt may publish in the future.

Co-authorship network of co-authors of Alexandre Jagerschmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Jagerschmidt. A scholar is included among the top collaborators of Alexandre Jagerschmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Jagerschmidt. Alexandre Jagerschmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gayvert, Kaitlyn, Martin Desrosiers, Tanya M. Laidlaw, et al.. (2024). Nasal brushing molecular endotyping distinguishes patients with chronic rhinosinusitis with nasal polyps with better response to dupilumab. Journal of Allergy and Clinical Immunology. 154(3). 619–630. 6 indexed citations
2.
Bachert, Claus, Tanya M. Laidlaw, Seong Cho, et al.. (2023). Effect of Dupilumab on Type 2 Biomarkers in Chronic Rhinosinusitis With Nasal Polyps: SINUS-52 Study Results. Annals of Otology Rhinology & Laryngology. 132(12). 1649–1661. 16 indexed citations
3.
Pavord, Ian, Thomas B. Casale, Jonathan Corren, et al.. (2022). Relation between reduction in fractional exhaled nitric oxide and efficacy in asthma patients treated with dupilumab. 2256–2256. 1 indexed citations
4.
Dürrbach, Antoine, Jean‐Charles Gautier, Catherine Lunven, et al.. (2021). Investigation of new biomarkers of kidney injury in renal transplant recipients undergoing graft biopsy. Clinical Transplantation. 35(9). e14408–e14408. 3 indexed citations
5.
Léger, Bertrand, Clara Dees, Christian Beyer, et al.. (2020). Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse. British Journal of Pharmacology. 177(18). 4296–4309. 20 indexed citations
6.
Bachert, Claus, Seong Cho, Tanya M. Laidlaw, et al.. (2020). Dupilumab Reduces Blood, Urine, and Nasal Biomarkers of Type 2 Inflammation in Patients With Chronic Rhinosinusitis With Nasal Polyps in the Phase 3 SINUS-52 Trial. Journal of Allergy and Clinical Immunology. 145(2). AB185–AB185. 5 indexed citations
7.
Bachert, Claus, Joaquim Mullol, Nadia Daizadeh, et al.. (2020). Dupilumab reduces blood and nasal biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma: SINUS-52 trial. Ghent University Academic Bibliography (Ghent University). 1117–1117. 1 indexed citations
8.
Raghu, Ganesh, Luca Richeldi, Alexandre Jagerschmidt, et al.. (2018). Idiopathic Pulmonary Fibrosis. CHEST Journal. 154(6). 1359–1370. 57 indexed citations
9.
Pavord, Ian, Klaus F. Rabe, Alberto Papi, et al.. (2018). Dupilumab shows rapid and sustained suppression of inflammatory biomarkers in asthma patients in LIBERTY ASTHMA QUEST. PA5005–PA5005. 5 indexed citations
10.
Allanore, Yannick, Oliver Distler, Alexandre Jagerschmidt, et al.. (2018). Double-blind, Randomized, 8-week Placebo-controlled followed by a 16-week open label extension study, with the LPA1 receptor antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis. Zurich Open Repository and Archive (University of Zurich). 70(10). 1634–1643. 34 indexed citations
11.
12.
Allanore, Yannick, Oliver Distler, Alexandre Jagerschmidt, et al.. (2017). Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis. Arthritis & Rheumatology. 70(10). 1634–1643. 80 indexed citations
13.
Allanore, Yannick, et al.. (2015). OP0266 Lysophophatidic Acid Receptor 1 Antagonist SAR100842 as a Potential Treatment for Patients with Systemic Sclerosis: Results from a Phase 2A Study. Annals of the Rheumatic Diseases. 74. 172–173. 4 indexed citations
14.
Khanna, Dinesh, et al.. (2014). SAR100842, an Antagonist of Lysophaphatidic Acid Receptor 1, As a Potential Treatment for Patients with Systemic Sclerosis: Results from a Phase 2a Study.. UCL Discovery (University College London). 3 indexed citations
15.
16.
Jagerschmidt, Alexandre, et al.. (1998). Human thrombopoietin structure–function relationships: identification of functionally important residues. Biochemical Journal. 333(3). 729–734. 11 indexed citations
17.
Jagerschmidt, Alexandre, et al.. (1996). His381 of the rat CCKB receptor is essential for CCKB versus CCKA receptor antagonist selectivity. European Journal of Pharmacology. 296(1). 97–106. 32 indexed citations
18.
Jagerschmidt, Alexandre, et al.. (1995). Mutation of Asp100 in the second transmembrane domain of the cholecystokinin B receptor increases antagonist binding and reduces signal transduction.. Molecular Pharmacology. 48(5). 783–789. 33 indexed citations
19.
Jagerschmidt, Alexandre, T. Popovici, Marie-Françoise O’Donohue, & B.P. Roques. (1994). Identification and characterization of various cholecystokinin B receptor mRNA forms in rat brain tissue and determination of the cholecystokinin B receptor gene structure. Neuropeptides. 26. 2–3. 1 indexed citations
20.
Jagerschmidt, Alexandre, T. Popovici, Michael O’Donohue, & B.P. Roques. (1994). Identification and Characterization of Various Cholecystokinin B Receptor mRNA Forms in Rat Brain Tissue and Partial Determination of the Cholecystokinin B Receptor Gene Structure. Journal of Neurochemistry. 63(4). 1199–1206. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chiyuki Furukawa Breakdown of academic impact, for papers by Alison Kraus Breakdown of academic impact, for papers by TaeJeong Oh Breakdown of academic impact, for papers by Vincenzo Ciocca Breakdown of academic impact, for papers by Fiamma Berner Breakdown of academic impact, for papers by Mitchell I. Parker Breakdown of academic impact, for papers by Yasuhito Tonomoto Breakdown of academic impact, for papers by Kayo Ijichi Breakdown of academic impact, for papers by Sandra Gallagher Breakdown of academic impact, for papers by Takanobu Ubai
Rankless by CCL
2026